Triple-negative breast cancer (TNBC), a specific subtype of breast cancer that does not
express estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth …

Although recent advances in curative-intent therapies are beginning to produce significant
survival gains in early breast cancer, these improvements may ultimately be attenuated by …

Today, cancer treatment is an important issue in the medical world due to the challenges
and side effects of ongoing treatment procedures. Current methods can be replaced with …

Simple Summary Triple-negative breast cancer (TNBC) is a highly aggressive subtype of
breast cancer that cannot be treated with endocrine therapy and Her2-targeted therapy …

Despite an increase in the incidence of breast cancer worldwide, overall prognosis has
been consistently improving owing to the development of multiple targeted therapies and …

Background Cancer treatment with a variety of chemotherapeutic agents often is associated
with delayed adverse neurological consequences. Despite their clinical importance, almost …

Cardiovascular toxicity is one of the most devastating complications of cancer treatment and
can arise during or shortly after treatment, or even several years later. Identification of the left …

Breast cancer is the most common malignancy in women. Successful treatment of breast
cancer relies on a better understanding of the molecular mechanisms involved in breast …

Background Taxanes are among the most active drugs for the treatment of metastatic breast
cancer, and, as a consequence, they have also been studied in the adjuvant setting …

Tumor heterogeneity of triple-negative breast cancer (TNBC) has been the main barrier in
conquering breast cancer. To dissect the molecular diversity of TNBC and discover …